BIO.News Newsletter

There’s a lot happening on the Hill today, including BIO’s Dr. Cartier Esham testifying on advancing treatments and cures for neurodegenerative diseases, and Senate Ag considering key USDA nominees. Ahead of National Immunization Awareness Month, we also recap a conversation yesterday about how we can advance vaccinations. (893 words, 4 minutes, 27 seconds)

From ag biotech in Mexico, to pandemic preparedness in the U.S., it was a busy day on Capitol Hill yesterday as BIO’s Dr. Michelle McMurry-Heath and Phyllis Arthur testified on these important topics. We have a recap, plus more news from D.C. (868 words, 4 minutes, 20 seconds)

It’s a busy day in Washington, with BIO’s Dr. Michelle McMurry-Heath testifying about Mexico’s treatment of agricultural biotech, and BIO’s Phyllis Arthur testifying about lessons learned from COVID-19. Meanwhile, we have details on the “21st Century Cures Act 2.0” and BIO’s take on how we can best modernize it. (855 words, 4 minutes, 16 seconds)

Starting the last week of July with a look at a recent report on human genome editing from the WHO's Expert Committee, as well as what we know about how to combat vaccine hesitancy. (762 words, 3 minutes, 48 seconds)

ICYMI: African swine fever is making a comeback in Germany—this time in farm pigs. We explain how we could end this disease, as well as recap what BIO’s Dr. Michelle said during a Washington Post event about health equity. (770 words, 3 minutes, 51 seconds)

Lots of newness today: the new COVAX Marketplace, BIO’s new VP for Agriculture and Environment, and more news from Washington. (888 words, 4 minutes, 26 seconds)

Today, we have a quick recap of yesterday’s Senate hearing on the federal COVID-19 response, plus a look at a must-read long-read on how the tide is turning on GMOs and why it matters. (842 words, 4 minutes, 12 seconds)

Today, we look at a recent report that has both good and bad news on cancer deaths in the U.S., as well as how gene editing can make biryani ingredients more sustainable and resilient. (772 words, 3 minutes, 51 seconds)

We start a new week bearing bad news: COVID cases are rising across the U.S., and extreme climate events are increasing around the world. Fortunately, biotech can deliver solutions to both challenges—but we have some work to do to get them where they need to go. (766 words, 3 minutes, 49 seconds)

Closing the week with a promising bipartisan bill that would establish an out-of-pocket cap for Medicare Part D beneficiaries, as well as USDA’s nominee to oversee marketing and regulatory programs. Plus—we have an inspiring new I am BIO video to start your weekend right. (851 words, 4 minutes, 31 seconds)